161 related articles for article (PubMed ID: 790316)
21. Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Nissen NI; Pajak T; Glidewell O; Blom H; Flaherty M; Hayes D; McIntyre R; Holland JF
Cancer Treat Rep; 1977 Sep; 61(6):1097-107. PubMed ID: 71208
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
24. Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy.
Canellos GP; DeVita VT; Young RC; Chabner BA; Schein PS; Johnson RE
Br J Cancer Suppl; 1975 Mar; 2():474-80. PubMed ID: 1101933
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors of invasive non-Hodgkin's lymphoma].
Yu H; Hong XN; Li J; Peng LP; Ye L
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284
[TBL] [Abstract][Full Text] [Related]
26. [Chemotherapy for advanced non-Hodgkin's lymphoma with CVP therapy].
Horikoshi N; Inagaki J; Ogawa M
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1885-91. PubMed ID: 6683954
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.
Coltman CA; Luce JK; McKelvey EM; Jones SE; Moon TE
Cancer Treat Rep; 1977 Sep; 61(6):1067-78. PubMed ID: 71206
[TBL] [Abstract][Full Text] [Related]
28. Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Pouillart P; Hayat M; Schwarzenberg L; Amiel JL; Mathé G; Tubiana M
Br J Cancer Suppl; 1975 Mar; 2():505-11. PubMed ID: 52369
[TBL] [Abstract][Full Text] [Related]
29. The influence of chemotherapy on the management of non-Hodgkin's lymphomata at the Princess Margaret Hospital. A comparison of the results from 1962-64 with 1967-69.
Bergsagel DE; Brown TC; Reid J
Br J Cancer Suppl; 1975 Mar; 2():489-96. PubMed ID: 1101934
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Seymour JF; Pro B; Fuller LM; Manning JT; Hagemeister FB; Romaguera J; Rodriguez MA; Ha CS; Smith TL; Ayala A; Hess M; Cox JD; Cabanillas F; McLaughlin P
J Clin Oncol; 2003 Jun; 21(11):2115-22. PubMed ID: 12775737
[TBL] [Abstract][Full Text] [Related]
31. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
Klein HO
Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
[No Abstract] [Full Text] [Related]
32. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
Rossini F; Terruzzi E; Perego D; Miccolis I; Rivolta F; Manca E; Pogliani EM
Cancer; 2004 Jan; 100(2):350-5. PubMed ID: 14716771
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
34. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
Yuan ZY; Xu RH; He YJ; Guan ZZ
Ai Zheng; 2003 Apr; 22(4):393-6. PubMed ID: 12703996
[TBL] [Abstract][Full Text] [Related]
35. [Results of the synchronization therapy with vincristine and cyclophosphamide in lymphogranulomatosis, reticulum cell sarcoma and lymphosarcoma. A phase II study (author's transl)].
Klein HO; Gerecke D; Borberg H; Gross R; Hoefer-Janker H; Scheef W; Diehl V; Lohmann E; Adler D; Buter E; Löhning A; Brock N; Burkert H
Dtsch Med Wochenschr; 1975 Aug; 100(35):1719-26. PubMed ID: 1098886
[TBL] [Abstract][Full Text] [Related]
36. [Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
Misset JL; Pouillart P; Amiel JL; Schwarzenberg L; Hayat M; de Vassal F; Musset M; Belpomme D; Jasmin C; Albahary C; Depierre R; Mathé G
Nouv Presse Med; 1975 Dec; 4(44):3117-20. PubMed ID: 768904
[TBL] [Abstract][Full Text] [Related]
37. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
[TBL] [Abstract][Full Text] [Related]
38. 5-year survey of methotrexate, cyclophosphamide (Endoxan), and vincristine (MEV) therapy for advanced non-Hodgkin's lymphomas.
Lauria F; Baccarani M; Fiacchini M; Frezza R; Gobbi M; Tura S
Cancer Treat Rep; 1978 Aug; 62(8):1193-7. PubMed ID: 688255
[TBL] [Abstract][Full Text] [Related]
39. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients.
Morgenfeld MC; Pavlovsky A; Suarez A; Somoza N; Pavlovsky S; Palau M; Barros CA
Cancer; 1975 Oct; 36(4):1241-9. PubMed ID: 1100220
[TBL] [Abstract][Full Text] [Related]
40. 1,3-bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP). A new therapeutic regimen for diffuse histiocytic lymphoma.
Durant JR; Loeb V; Dorfman R; Chan YK
Cancer; 1975 Dec; 36(6):1936-44. PubMed ID: 1106833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]